Quick answer
How should CJC-1295 (No DAC) be stored for laboratory research? Keep the sealed lyophilized vial refrigerated at 2–8 °C for near-term work and at −20 °C for long-term holding, away from heat, moisture and light. Reconstituted stock should be kept cold, portioned into single-use tubes if it will be held for long, and thawed only once. No validated shelf life has been published for the reconstituted peptide, so concentration-critical work should be re-checked by HPLC. Volumes come from the reconstitution calculator.
What the vial contains and what the product page states
The CJC-1295 (No DAC) product page lists 5 mg and 10 mg vials of lyophilized powder in a sealed clear glass research vial, with purity stated as ≥98% by HPLC. The molecular formula given is C152H252N44O42, and the sequence is written out residue by residue. The storage line reads: refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light. The page notes that the certificate of analysis for this item is in progress, so check the COA library for the lot in hand and record what it shows, or record that none is listed yet.
Those four storage conditions are the whole of the supplier-side guidance. Everything else in this article is the reasoning a bench scientist can add to it: why the sequence of a short GHRH analog makes it comparatively forgiving, where the weak points still are, and how to design a small in-house stability check instead of trusting a shelf-life figure that nobody has published.
Four sequence features that shape stability
CJC-1295 without DAC is the 29-residue analog usually catalogued as modified GRF (1-29). Reading its sequence against the native GHRH(1-29) fragment (Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg) shows four differences, and each one is relevant to storage.
| Position | Native GHRH(1-29) | CJC-1295 (No DAC) | Storage relevance |
|---|---|---|---|
| 2 | Ala | D-Ala | Native GHRH is cleaved after residue 2 by dipeptidyl peptidase IV (Frohman and colleagues, 1989). A D-amino acid at this position is a design response to that enzyme; it matters in biological media, not in a dry vial. |
| 8 | Asn | Gln | At pH 7.4 and 37 °C the major degradation products of a GRF analog arose from deamidation of Asn8, and analogs carrying Ser8 kept full potency over 14 days while Asn8 analogs lost it (Friedman and colleagues, 1991). Gln is not Ser, and that study did not test this peptide, so read the substitution as a reduced liability, not a proven one. |
| 15 | Gly | Ala | No chemical liability is added; the change is part of the analog design rather than a storage feature. |
| 27 | Met | Substituted (non-sulfur residue) | Methionine is the classic oxidation site in peptides (Li and colleagues, 1995). A position-27 substitution that removes the sulfur means methionine sulfoxide cannot form here. |
The practical reading is that two of the best-known chemical weak points of the parent sequence, Asn8 deamidation and Met27 oxidation, are reduced or removed in this analog. That does not make the peptide inert. It still has a free N-terminus, an aspartate at position 3 and another at position 25, tyrosines at positions 1 and 10, and a long, positively charged stretch of arginine and lysine residues. Those residues leave room for aspartate isomerization, tyrosine oxidation, adsorption to glass and plastic, and aggregation in concentrated or agitated solution.
Storage tiers for powder and solution
The product page defines two temperature tiers. The table maps them onto the states a vial actually passes through. It gives no day-counts, because no validated shelf life has been published for research-grade reconstituted CJC-1295 (No DAC), and a number quoted without data would be invention.
| State | Temperature tier | Handling notes |
|---|---|---|
| Sealed lyophilized vial, in near-term use | 2–8 °C | Keep boxed, toward the back of the refrigerator and away from the door |
| Sealed lyophilized vial, reserve stock | −20 °C | Use a manual-defrost freezer where possible; frost-free cycles warm the contents repeatedly |
| Vial on the bench or in transit | Ambient, briefly | Return to cold storage on receipt and note the arrival condition |
| Reconstituted stock, multi-entry | 2–8 °C | Preserved diluent only; swab the stopper before each entry; inspect each time |
| Reconstituted stock, portioned | −20 °C, single-use portions | Thaw once, mix by slow inversion, never refreeze as routine |
| Working dilution in buffer or medium | Prepared on the day | Discard the remainder; do not return it to storage |
Background on why cold slows chemical change and why the dry state outlasts solution is covered in storing research peptides and how long do reconstituted peptides last. The general behavior is well established: degradation rates fall with temperature, and water is a participant in the main chemical pathways (Manning and colleagues, 2010).
Degradation pathways to watch for
Because the headline liabilities are reduced or removed, the remaining pathways are slower and subtler. The table lists each one with the physical sign, if any, and how a laboratory would detect it.
| Pathway | Where it acts | Visible sign | How it is detected |
|---|---|---|---|
| Aspartate isomerization or cleavage | Asp3, Asp25 and neighboring residues | None | Shifted or split HPLC peak, mass-spectrometry fragments |
| Deamidation of Gln | Gln8, Gln16, Gln24; far slower than for Asn | None | Small mass shift of +1 Da, usually resolved only by high-resolution methods |
| Tyrosine oxidation | Tyr1 and Tyr10 under light or trace metals | None, sometimes slight tint | Peak broadening, extra early peaks in HPLC |
| Aggregation | Concentrated solution, agitation, freeze–thaw | Haze, opalescence, strands | Size-exclusion chromatography, light scattering |
| Adsorption loss | Glass and plastic surfaces, dilute solution | None | Falling recovered concentration, not a purity change |
| Backbone hydrolysis | Acidic solution, heat | None | Truncated fragments in HPLC |
Forced-degradation studies, in which a peptide is stressed with heat, light, oxidant or extreme pH to learn which products form, are the standard way of mapping these pathways (Hawe and colleagues, 2012). A research laboratory rarely needs to repeat one in full, but the logic transfers: if an experiment is sensitive to a particular product, test for that product.
Reconstitution choices that protect stability
Storage begins at reconstitution. Let the cold vial reach room temperature before the stopper is pierced, so that condensation does not enter. Direct the diluent down the inside glass wall rather than onto the cake, swirl gently, and wait; do not shake, vortex or sonicate. A 29-residue peptide with several hydrophobic residues (Ile, Phe, Leu, Val) and a strongly basic C-terminal half is more likely to foam than a short tripeptide, and foam means air–water interface, which is where peptides unfold and aggregate.
Use bacteriostatic water for a vial that will be entered several times and sterile water for a stock that is portioned and frozen at once; the trade-offs are set out in bacteriostatic water explained. Step-by-step mechanics are in how to reconstitute a lyophilized peptide. The concentration of the stock follows from one formula: concentration equals vial mass divided by diluent volume. The reconstitution calculator does the arithmetic, and the figures should be written down before any liquid is drawn.
Freeze–thaw cycles, light and adsorption
Freeze–thaw. When a solution freezes, solutes concentrate in the remaining liquid and ice forms; freeze-concentration can also favor second-order reactions, buffer crystallization and redistribution of solutes (Bhatnagar and colleagues, 2007). The usual answer is to portion the stock into single-use tubes immediately after reconstitution so that no tube is ever refrozen. If one must be, write the cycle count on the label and carry it into the experimental record.
Light. Clear glass transmits room light and ultraviolet. Tyrosine is among the residues susceptible to oxidation, and oxidation can be induced by light and catalyzed by transition metal ions (Li and colleagues, 1995). Keeping vials in their box is enough for routine work.
Adsorption. Peptide loss to container walls is measurable and unpredictable: recovery varied widely between peptides and between glass and plastic surfaces, siliconizing the tubes decreased recovery and adding bovine serum albumin improved it (Goebel-Stengel and colleagues, 2011). Test the container for the peptide in hand, keep transfers few and make dilutions immediately before use. Carrier protein in the working buffer helps if the protocol allows it.
Designing an in-house stability check
Where an experiment depends on stock concentration holding for weeks, the sound approach is to measure it. A small design needs only the stock, a time schedule and an analytical method already available in most peptide laboratories.
- Time zero. Run an HPLC trace of the freshly prepared stock and keep the chromatogram; this is the reference for peak area and for the impurity profile. The principles of reading the trace are in understanding HPLC purity.
- Storage arms. Portion the stock and hold portions at 2–8 °C and at −20 °C; add a room-temperature arm only if bench exposure is part of the real workflow.
- Time points. Choose points that bracket the intended experiment length and re-run the same method on a fresh portion at each; never re-sample from a tube already entered.
- Readouts. Compare main-peak area at the same sample volume, new peaks and any shift in retention time; note appearance at each point.
- Decision rule. Define before starting what change counts as acceptable for the assay in question, so the result is a decision rather than an impression.
Identity at time zero comes from the certificate of analysis where one is published, read as described in how to read a COA; HPLC alone shows purity and retention behavior, and mass spectrometry is the method that confirms molecular mass (HPLC vs mass spectrometry).
Records and labelling
A reconstituted peptide without a label is an unknown. The container should carry the compound, lot number, diluent, concentration, preparation date and initials. The notebook entry adds the lot's certificate status, the appearance of the powder on receipt, the calculated and actual diluent volume, the appearance of the solution, the storage position, each date a vial was entered, and the freeze–thaw count of any portion used. These notes take a minute and are the only means of explaining a drifting result weeks later.
What not to do
- Do not open a vial straight from the freezer or refrigerator.
- Do not shake, vortex or sonicate a solution.
- Do not store working dilutions in assay buffer or culture medium.
- Do not keep an unpreserved sterile-water solution as a refrigerated multi-entry vial.
- Do not refreeze thawed portions as routine practice.
- Do not mix CJC-1295 (No DAC) with another peptide in one stock vial unless the combination has been validated; blend behavior is discussed in CJC-1295 and ipamorelin reconstitution and storage.
What is and is not published
The published literature on GHRH analogs describes their design, enzymatic degradation in plasma and receptor behavior. It does not supply a validated shelf life for a research-grade lyophilized vial reconstituted in water. Any figure such as "stable for N days" is therefore a convention or an in-house result, not a literature value. What can be stated with confidence is general: the dry state is far more stable than solution, lower temperature slows chemical change, and aggregation risk rises with agitation, heat and repeated freezing. Related comparisons of the molecule with its neighbors are in the CJC-1295 (No DAC) research overview, and the purity side of quality is covered in CJC-1295 (No DAC) purity testing.
All material discussed is supplied for laboratory research use only; not for human consumption.
Related reading
- CJC-1295 (No DAC) research overview
- CJC-1295 (No DAC) purity testing
- Where to buy CJC-1295 (No DAC) for research
- CJC-1295 DAC vs No DAC research comparison
Frequently asked questions
At what temperature should CJC-1295 (No DAC) be stored?
The product page states: refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light. Vials for near-term work stay refrigerated; reserve vials go to a freezer.
Why is CJC-1295 (No DAC) considered chemically sturdier than native GHRH?
Compared with the native 1-29 fragment it carries Gln in place of Asn at position 8 and a position-27 substitution in place of methionine, which replaces an asparagine of the kind that deamidated in a related analog and removes an oxidizable methionine. It is still a peptide and still degrades by other routes.
How long does reconstituted CJC-1295 (No DAC) last?
No validated shelf life has been published for research-grade material reconstituted in water. Laboratories keep solutions cold, limit time in solution, freeze single-use portions and re-check by HPLC when concentration matters.
Can CJC-1295 (No DAC) be frozen after reconstitution?
Yes, as single-use portions frozen straight after preparation. Plan for one freeze and one thaw, because repeated cycles concentrate the peptide and create ice interfaces that encourage aggregation.
Does light matter for a clear glass vial?
Possibly. Clear glass passes room light, and oxidation of residues such as tyrosine can be induced by light. Keeping the vial in its box is sufficient for routine work.
Does the powder look different if it has degraded?
Not reliably. A broken or collapsed cake is usually cosmetic, but chemical degradation is invisible. A wet, glassy or discolored solid should be noted in the receiving record before use.
Is the D-Ala at position 2 a storage feature?
It is a design feature aimed at dipeptidyl peptidase IV, an enzyme found in biological media. It does not change how the dry powder or a clean aqueous stock should be stored.
How is the stock concentration worked out?
Concentration equals vial mass divided by diluent volume. The vial mass is fixed, so the volume only sets the concentration; use the reconstitution calculator and record the figures.
Does CJC-1295 (No DAC) stick to tubes?
Peptide recovery from glass and plastic surfaces varies widely and is hard to predict. Test the container, keep transfers few, make dilutions fresh and, where the assay allows, add carrier protein.
What should be recorded for each vial?
Compound, lot, certificate status, diluent, concentration, preparation date, storage position, each date of entry and the freeze–thaw count of any portion.
Related reading: High-Purity CJC-1295 No DAC: What to Verify.
References
- Frohman LA, Downs TR, Heimer EP, Felix AM. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest. 1989;83(5):1533-1540. doi:10.1172/JCI114049
- Friedman AR, Ichhpurani AK, Brown DM, et al. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Int J Pept Protein Res. 1991;37(1):14-20. doi:10.1111/j.1399-3011.1991.tb00727.x
- Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490-500. doi:10.1002/bit.260480511
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
